Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis

Front Pharmacol. 2023 May 30:14:1219760. doi: 10.3389/fphar.2023.1219760. eCollection 2023.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.838449.].

Keywords: ILDs; IPF; PDE4B; cAMP; lung fibrosis; phosphodiesterase.

Publication types

  • Published Erratum